Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) Delivers a Reduction and Delay in Worsening of Pain Symptoms for Patients with Newly Diagnosed Multiple Myeloma Ineligible for Transplant

Katharine Gries; Thierry Facon; Torben Plesner; Saad Usmani; Shaji Kumar; Robert Z. Orlowski; Nizar J. Bahlis; Hareth Nahi; Peter Mollee; Karthik Ramasamy; Murielle Roussel; Michel Delforge; Lionel Karlin; Bertrand Arnulf; Ajai Chari; Cyrille Hulin; Katja Weisel; Jianming He; Kai Fai Ho; Jim Wang; Rian Van Rampelbergh; Clarissa Uhlar; Rachel Kobos; Aurore Perrot

doi:10.1016/j.clml.2019.09.375

Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) Delivers a Reduction and Delay in Worsening of Pain Symptoms for Patients with Newly Diagnosed Multiple Myeloma Ineligible for Transplant

Katharine Gries, Thierry Facon, Torben Plesner, Saad Usmani, Shaji Kumar, Robert Z. Orlowski, Nizar J. Bahlis, Hareth Nahi, Peter Mollee, Karthik Ramasamy, Murielle Roussel, Michel Delforge, Lionel Karlin, Bertrand Arnulf, Ajai Chari, Cyrille Hulin, Katja Weisel, Jianming He, Kai Fai Ho, Jim WangRian Van Rampelbergh, Clarissa Uhlar, Rachel Kobos, Aurore Perrot

IRS - Sygehus Lillebælt, Forskningsenhed for Hæmatologi (Vejle)

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Clinical Lymphoma Myeloma and Leukemia
Vol/bind	19
Udgave nummer	10 Supplement
Sider (fra-til)	E225-E226
ISSN	2152-2650
DOI	https://doi.org/10.1016/j.clml.2019.09.375
Status	Udgivet - okt. 2019
Begivenhed	17th International Myeloma Workshop - Boston, USA Varighed: 12. sep. 2019 → 15. sep. 2019

Konference

Konference	17th International Myeloma Workshop
Land/Område	USA
By	Boston
Periode	12/09/2019 → 15/09/2019

Dokumenter og links

10.1016/j.clml.2019.09.375

Citationsformater

Gries, K., Facon, T., Plesner, T., Usmani, S., Kumar, S., Orlowski, R. Z., Bahlis, N. J., Nahi, H., Mollee, P., Ramasamy, K., Roussel, M., Delforge, M., Karlin, L., Arnulf, B., Chari, A., Hulin, C., Weisel, K., He, J., Ho, K. F., ... Perrot, A. (2019). Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) Delivers a Reduction and Delay in Worsening of Pain Symptoms for Patients with Newly Diagnosed Multiple Myeloma Ineligible for Transplant. Clinical Lymphoma Myeloma and Leukemia, 19(10 Supplement), E225-E226. https://doi.org/10.1016/j.clml.2019.09.375

@article{b26188d0fafc4d25bfcc465e1f28760b,

title = "Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) Delivers a Reduction and Delay in Worsening of Pain Symptoms for Patients with Newly Diagnosed Multiple Myeloma Ineligible for Transplant",

author = "Katharine Gries and Thierry Facon and Torben Plesner and Saad Usmani and Shaji Kumar and Orlowski, {Robert Z.} and Bahlis, {Nizar J.} and Hareth Nahi and Peter Mollee and Karthik Ramasamy and Murielle Roussel and Michel Delforge and Lionel Karlin and Bertrand Arnulf and Ajai Chari and Cyrille Hulin and Katja Weisel and Jianming He and Ho, {Kai Fai} and Jim Wang and {Van Rampelbergh}, Rian and Clarissa Uhlar and Rachel Kobos and Aurore Perrot",

year = "2019",

month = oct,

doi = "10.1016/j.clml.2019.09.375",

language = "English",

volume = "19",

pages = "E225--E226",

journal = "Clinical Lymphoma Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Elsevier",

number = "10 Supplement",

note = "17th International Myeloma Workshop ; Conference date: 12-09-2019 Through 15-09-2019",

}

Gries, K, Facon, T, Plesner, T, Usmani, S, Kumar, S, Orlowski, RZ, Bahlis, NJ, Nahi, H, Mollee, P, Ramasamy, K, Roussel, M, Delforge, M, Karlin, L, Arnulf, B, Chari, A, Hulin, C, Weisel, K, He, J, Ho, KF, Wang, J, Van Rampelbergh, R, Uhlar, C, Kobos, R & Perrot, A 2019, 'Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) Delivers a Reduction and Delay in Worsening of Pain Symptoms for Patients with Newly Diagnosed Multiple Myeloma Ineligible for Transplant', Clinical Lymphoma Myeloma and Leukemia, bind 19, nr. 10 Supplement, s. E225-E226. https://doi.org/10.1016/j.clml.2019.09.375

Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) Delivers a Reduction and Delay in Worsening of Pain Symptoms for Patients with Newly Diagnosed Multiple Myeloma Ineligible for Transplant. / Gries, Katharine; Facon, Thierry; Plesner, Torben et al.
I: Clinical Lymphoma Myeloma and Leukemia, Bind 19, Nr. 10 Supplement, 10.2019, s. E225-E226.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

TY - ABST

T1 - Daratumumab, Lenalidomide, and Dexamethasone (D-Rd) Delivers a Reduction and Delay in Worsening of Pain Symptoms for Patients with Newly Diagnosed Multiple Myeloma Ineligible for Transplant

AU - Gries, Katharine

AU - Facon, Thierry

AU - Plesner, Torben

AU - Usmani, Saad

AU - Kumar, Shaji

AU - Orlowski, Robert Z.

AU - Bahlis, Nizar J.

AU - Nahi, Hareth

AU - Mollee, Peter

AU - Ramasamy, Karthik

AU - Roussel, Murielle

AU - Delforge, Michel

AU - Karlin, Lionel

AU - Arnulf, Bertrand

AU - Chari, Ajai

AU - Hulin, Cyrille

AU - Weisel, Katja

AU - He, Jianming

AU - Ho, Kai Fai

AU - Wang, Jim

AU - Van Rampelbergh, Rian

AU - Uhlar, Clarissa

AU - Kobos, Rachel

AU - Perrot, Aurore

PY - 2019/10

Y1 - 2019/10

U2 - 10.1016/j.clml.2019.09.375

DO - 10.1016/j.clml.2019.09.375

M3 - Conference abstract in journal

SN - 2152-2650

VL - 19

SP - E225-E226

JO - Clinical Lymphoma Myeloma and Leukemia

JF - Clinical Lymphoma Myeloma and Leukemia

IS - 10 Supplement

T2 - 17th International Myeloma Workshop

Y2 - 12 September 2019 through 15 September 2019

ER -